N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Clinical Trial ID NCT00093353

PubWeight™ 2.08^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00093353

Top papers